Instead of defying time, we awaken the body's inherent healing power. Through our AI-MSC platform and stem cell technology, we restore your fundamental biological rhythm.
Soft AgingTM PhilosophyBy 2050, the aging population will hit 2.1 billion. Conventional 'Anti-Aging,' focused on forcing back time, has revealed its limits and side effects. Merely masking symptoms cannot extend true healthspan.
2.1 Billion
trending_up+15% GrowthProjected population over 60 by 2050
We chose a different path. Do not fight time. Soft Aging™ respects your biological ecosystem. Instead of temporary chemical dependence, we awaken the body’s innate ability to heal and overcome disease.
We design the destiny of stem cells. Qgenetics' proprietary AI-MSC platform integrates AI Big Data mining with advanced Medichem to perfectly control the differentiation of Mesenchymal Stem Cells (MSC).
Our AI algorithms analyze vast datasets to identify optimal therapeutic targets that maximize cellular autonomy without side effects.
Beyond simple cell injection. Our advanced medicinal chemistry directs stem cells to precisely differentiate into bone, muscle, or cartilage cells.
FIRST-IN-CLASS
The world’s first-in-class oral osteoanabolic therapeutic.
Directly promotes osteoblast differentiation.
Proven exceptional safety in Phase 1 trials.
PIPELINE EXPANSION
• Obesity (QG30-OB): Reduces visceral fat without muscle loss.
• Osteoarthritis: Fundamental treatment via chondrocyte regeneration.
MEDICAL DEVICE
Next-generation synthetic bone graft replacing BMP-2.
Superior osteoinductivity with zero risk of side effects.
Chief Executive Officer
Chief Technology Officer
Chief Development Officer
